SuppliersPortugalMedical equipments, pharmaceuticals and personal care productsLILLY PORTUGAL - PRODUTOS FARMACEUTICOS

LILLY PORTUGAL - PRODUTOS FARMACEUTICOS

Public recordUnclaimedSME

224 public contract awards in 2026 to date across 41 public buyers in Portugal, from BASE.gov records.

NIF 500165602 · CPV 33600000 Pharmaceutical products · CPV 33000000 Medical equipments, pharmaceuticals and personal care products · Register edition 15 Aug 2026

The record in one paragraph

LILLY PORTUGAL - PRODUTOS FARMACEUTICOS (NIF 500165602) won 224 public contracts worth €27,232,291 from 41 public buyers in Portugal in 2026 to date. Its largest public buyer by value is Unidade Local de Saúde de Santa Maria, E. P. E., with €3,524,396 across 12 contracts. Nearly all of that value, over 99.9% of it, sits in CPV division 33, Medical equipments, pharmaceuticals and personal care products. Source: Portal BASE (base.gov.pt), IMPIC open data, register edition 15 Aug 2026.

224Wins, 2026 to date
€27.2mAwarded value
41Public buyers
PortugalMarkets

Recent awards

Showing 10 of 224
Serviço de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM, EPERAM)13 Aug 2026 · Framework call-offINIBIDORES DE TIROSINACINASES - ABEMACICLIB - 3 MESES€27,060BASE.gov
Unidade Local de Saude Amadora/Sintra, E.P.E.11 Aug 2026 · Framework call-offAquisição de BARICITINIB ORAL 2 MG COMP, ao abrigo do AQ 2023-491, para a ULSASI, para o ano de 2026€4,583BASE.gov
Unidade Local de Saúde de Santa Maria, E. P. E.10 Aug 2026 · Other procedure261x000209 - SELPERCAtinib 80 MG CAPS/COMP€21,399BASE.gov
Unidade Local de Saúde de Lisboa Ocidental, E. P. E.6 Aug 2026 · Direct award111024426 - Aquisição de Tadalafil (Adcirca) (PCF) - ULSLO, EPE, 2026€14,437BASE.gov
Unidade Local de Saúde do Alto Alentejo E.P.E4 Aug 2026 · Direct awardAquisição medicamento exclusivo à Lilly - Selpercatinib€15,285BASE.gov
Unidade Local de Saúde de Almada-Seixal, EPE29 Jul 2026 · Direct awardABEMACICLIB 100 MG COMP€9,020BASE.gov
Unidade Local de Saude Amadora/Sintra, E.P.E.28 Jul 2026 · Other procedureAquisição de SELPERCATINIB ORAL 80MG COMP REV, AUE nº 202600830, ao Lab. Lilly, para a ULSASI, para…€36,684BASE.gov
Unidade Local de Saúde de Almada-Seixal, EPE28 Jul 2026 · Direct awardMIRICIZUMAB 300MG (20 MG/ML)SOL INJ FR 15 ML IV€7,799BASE.gov
Unidade Local de Saude Amadora/Sintra, E.P.E.24 Jul 2026 · Framework call-offAquisição de ABEMACICLIB ORAL 50MG COMP REV, ao abrigo do AQ 2023-491, para a ULSASI, para o ano de…€30,067BASE.gov
Unidade Local de Saúde do Baixo Alentejo, E.P.E.24 Jul 2026 · Framework call-offMEDICAMENTOS€48,107BASE.gov

Top buyers, 2026

EUR
Unidade Local de Saúde de Santa Maria, E. P. E.€3.5m
12 contracts
Unidade Local de Saúde do Algarve, EPE€2.5m
8 contracts
Instituto Português de Oncologia do Porto Francisco Gentil, EPE€1.9m
26 contracts
Unidade Local de Saúde de São João E.P.E.€1.9m
4 contracts
Unidade Local de Saúde de Santo António, E. P. E.€1.8m
4 contracts

Who else wins with these buyers

Questions about LILLY PORTUGAL - PRODUTOS FARMACEUTICOS

How much has LILLY PORTUGAL - PRODUTOS FARMACEUTICOS won in Portuguese public tenders in 2026?
LILLY PORTUGAL - PRODUTOS FARMACEUTICOS (NIF 500165602) was awarded €27,232,291 across 224 public contracts published on Portal BASE in 2026 to date, register edition 15 Aug 2026.
Which public bodies buy from LILLY PORTUGAL - PRODUTOS FARMACEUTICOS?
LILLY PORTUGAL - PRODUTOS FARMACEUTICOS won contracts from 41 public buyers in 2026 to date. The largest by value: Unidade Local de Saúde de Santa Maria, E. P. E. (€3,524,396), Unidade Local de Saúde do Algarve, EPE (€2,534,594), Instituto Português de Oncologia do Porto Francisco Gentil, EPE (€1,920,990). Source: Portal BASE, register edition 15 Aug 2026.
What does LILLY PORTUGAL - PRODUTOS FARMACEUTICOS supply?
The contracts LILLY PORTUGAL - PRODUTOS FARMACEUTICOS won in 2026 to date fall under CPV 33, Medical equipments, pharmaceuticals and personal care products; CPV 24, Chemical products, as the buyers classified them with CPV codes on Portal BASE, register edition 15 Aug 2026.
Who competes with LILLY PORTUGAL - PRODUTOS FARMACEUTICOS for the same buyers?
Generis Farmacêutica, S.A. (€21,120,347 awarded, 40 shared buyers), MYLAN, Lda (€17,502,862 awarded, 40 shared buyers), Overpharma, Lda. (€10,519,848 awarded, 40 shared buyers) won contracts from the same public buyers as LILLY PORTUGAL - PRODUTOS FARMACEUTICOS in 2026 to date, under the same CPV divisions, per Portal BASE, register edition 15 Aug 2026.
When was the most recent public contract of LILLY PORTUGAL - PRODUTOS FARMACEUTICOS?
The most recent contract on record for LILLY PORTUGAL - PRODUTOS FARMACEUTICOS is dated 13 Aug 2026, and the first of 2026 is dated 6 Jan 2026, per Portal BASE, register edition 15 Aug 2026.
Built from public procurement records: BASE.gov (IMPIC open data). Refreshed with each edition, last 15 Aug 2026. Not affiliated with LILLY PORTUGAL - PRODUTOS FARMACEUTICOS.Report an error · Request removal · 1,409 supplier pages